Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 26;32(1):11.
doi: 10.1186/s44348-024-00019-0.

2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, part I: aortic valve disease

Sun Hwa Lee  1 , Se-Jung Yoon  2 , Byung Joo Sun  3 , Hyue Mee Kim  4 , Hyung Yoon Kim  5 , Sahmin Lee  3 , Chi Young Shim  6 , Eun Kyoung Kim  7   8 , Dong-Hyuk Cho  9 , Jun-Bean Park  10 , Jeong-Sook Seo  11 , Jung-Woo Son  12 , In-Cheol Kim  13 , Sang-Hyun Lee  14   15 , Ran Heo  16 , Hyun-Jung Lee  6 , Jae-Hyeong Park  17   18 , Jong-Min Song  3 , Sang-Chol Lee  7   8 , Hyungseop Kim  13 , Duk-Hyun Kang  3 , Jong-Won Ha  6 , Kye Hun Kim  19 ; on the behalf of the Korean Valve Survey Investigators
Collaborators, Affiliations
Review

2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, part I: aortic valve disease

Sun Hwa Lee et al. J Cardiovasc Imaging. .

Erratum in

Abstract

This manuscript represents the official position of the Korean Society of Echocardiography on valvular heart diseases. This position paper focuses on the clinical management of valvular heart diseases with reference to the guidelines recently published by the American College of Cardiology/American Heart Association and the European Society of Cardiology. The committee tried to reflect the recently published results on the topic of valvular heart diseases and Korean data by a systematic literature search based on validity and relevance. In part I of this article, we will review and discuss the current position of aortic valve disease in Korea.

Keywords: Aortic regurgitation; Aortic stenosis; Echocardiography.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Treatment of aortic stenosis (AS): timing of intervention. AVA, aortic valve area; AVR, aortic valve replacement; BNP, B-type natriuretic peptide; EF, ejection fraction; HG, high gradient; LEF, low ejection fraction; LF, low flow; LG, low gradient; LVEF, left ventricular ejection fraction; MG, mean pressure gradient; NEF, normal ejection fraction; NF, normal flow; SE, stress echocardiography; SVI, stroke volume index; Vmax, peak aortic jet velocity. aThe American College of Cardiology/American Heart Association guideline [1] and the European Society of Cardiology guidelines [2] recommend AVR for asymptomatic AS patients with Vmax ≥ 5.0 m/sec. bTransesophageal echocardiography, cardiac computed tomography with aortic valve calcium score, or cardiac magnetic resonance imaging should be considered
Fig. 2
Fig. 2
Treatment of aortic stenosis (AS): choice of intervention. AVR, aortic valve replacement; SAVR; surgical aortic valve replacement; STS, Society of Thoracic Surgeons; PROM, 30-day predicted risk of mortality score; TAVR, transcatheter aortic valve replacement
Fig. 3
Fig. 3
Treatment of aortic regurgitation (AR). AV, aortic valve; LV, left ventricle; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; LVESDI, left ventricular end-systolic dimension index
See this image and copyright information in PMC

References

    1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143:e72-227. - PubMed
    1. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632. - PubMed
    1. Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, et al. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme valvular heart disease II survey. Circulation. 2019;140:1156–69. - PubMed
    1. Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990–2017. Circulation. 2020;141:1670–80. - PubMed
    1. d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37:3515–22. - PMC - PubMed

LinkOut - more resources